Last reviewed · How we verify
NCT06191952
Davos Alzheimer's Collaborative Healthcare System Preparedness to Increase Cognitive Assessment Rates for Older Adults
NA trial testing Cognigram in Subjective Cognitive Decline in 500 participants. Status unknown.
1 February 2024
Quick facts
| Lead sponsor | Ludwig-Maximilians - University of Munich |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 500 |
| Start date | 1 February 2023 |
| Primary completion | 1 February 2024 |
| Estimated completion | 1 February 2024 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Cognigram
- Subjective cognitive decline questionnaire (SCD-Q)
- blood-based biomarkers
- ki:elements digital speech biomarker for cognition (ki:e SB-C)
Conditions studied
- Subjective Cognitive Decline — all drugs for Subjective Cognitive Decline →
- Alzheimer Dementia — all drugs for Alzheimer Dementia →
Sponsor
Ludwig-Maximilians - University of Munich
Who can join
65 and older, any sex, with Subjective Cognitive Decline or Alzheimer Dementia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study the investigators explore a pragmatic strategy to increase cognitive screening rates in the community. The investigators will compare the monetary value of different combinations of SCD questionnaires, digital cognitive tests, and blood Alzheimer's Disease (AD) biomarkers to identify the best approach for primary care settings.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Motivation, Worries and Digital Affinity in Cognitive Screening - Qualitative Findings From the CogScreen Study.
Tegethoff P, Perneczky R, Taute M, Deckert A, et al · · 2026 · PMID 41738969 · DOI 10.1177/08919887261429558
Verify or expand the search:
- PubMed search for NCT06191952
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Subjective Cognitive Decline
Currently open trials in the same condition.
- NCT07511270 — Prediction of Cognitive Test Performance Using AI-Based Analysis of Narrative Speech · NA · recruiting
- NCT07085663 — Exergame-assisted Simultaneous Motor-cognitive Training for Middle-aged Old Adults in China · NA · recruiting
- NCT06002477 — Attentional Mechanisms in SCD · EARLY_PHASE1 · recruiting
- NCT06358404 — Developing a Peer Support Intervention for Depression in SCD · NA · recruiting
- NCT06335836 — The Effects of Social Isolation and Social Interaction on the Risk of Dementia Progression and Brain Function in SCD (Su · recruiting
Other Ludwig-Maximilians - University of Munich trials
Trials by the same sponsor.
- NCT07514520 — Decision-making, Ethical Consent, and Interactive Dialogue in Ongoing Neurocognitive Decline - DECISION · active not recruiting
- NCT07504965 — Dementia-friendly Apothecaries as a Resource for Mental Heath in the Elderly · recruiting
- NCT07100548 — A Qualitative Analysis of Youth Responses to Depression Education Delivered on Social Media · completed
- NCT07061600 — Enhancing Depression Literacy and Reducing Stigma in Adolescents Through Social Media · NA · completed
- NCT06749106 — Plaque Imaging in Routine Care to Detect Intraplaque Hemorrhage · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06191952 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ludwig-Maximilians - University of Munich
- Last refreshed: 11 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06191952.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing